
    
      This will be a 12-week, randomized, double blind, placebo-controlled safety and efficacy
      study in men and women ≥18 years of age with fasting triglycerides ≥500 mg/dL and <2000 mg/dL
      while following a Therapeutic Lifestyle changes (TLC) diet.
    
  